According to Tarsus Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.14 B. In 2022 the company made an earning of -$59.96 M a decrease over its 2021 earnings that were of -$12.49 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.14 B | 121.18% |
2022 | -$59.96 M | 380.03% |
2021 | -$12.49 M | -53.74% |
2020 | -$27 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -16.46% | ๐บ๐ธ USA |